Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.

Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (0)

No references identified in the available metadata. This does not establish that none exist.

    Cited by — these papers cite this paper (97)

    1. The 'Civilising' of Psychedelics: Pharmaceuticalisation from Below as a Part-Process of American and European Informalisation 2026-10-30 · Expand citations
    2. Efficacy and safety of psilocybin-assisted therapy for alcohol use disorder: A systematic review and meta-analysis 2026-10-08 · Expand citations
    3. Through the Looking-Glass: A Scoping Review of Psychological Mechanisms of Psychedelic-Assisted Therapy for Substance Use Disorders 2026-09-02 · Expand citations
    4. The Abuse Liability of Classic Psychedelics: A Methodological Critique and Assessment of the Quality of Evidence of Recent Studies 2026-08-18 · Expand citations
    5. Integration in classic psychedelic-assisted therapies for mental health conditions: A scoping review 2026-07-26 · Expand citations
    6. Revealing shortcomings in the assessment of psilocybin effects on OCD-related symptoms in preclinical and clinical studies: A systematic review 2026-07-01 · Expand citations
    7. Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations 2026-06-01 · Expand citations
    8. Rapid and Sensitive Detection of Psilocybin and Psilocin in Urine by Surface-Enhanced Raman Spectroscopy 2026-05-28 · Expand citations
    9. Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder 2026-05-26 · Expand citations
    10. Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care 2026-05-14 · Expand citations
    11. Therapeutic Potential of Psilocybin in Alcohol and Opioid Use Disorders: A Promising Role for Psychedelics 2026-04-30 · Expand citations
    12. Psilocybin use in Puerto Rico: Patterns, motivations, and personality correlates from an online survey 2026-04-15 · Expand citations
    13. Sex-specific increased reactivity of the PVT and prolonged PVT→CeA circuit engagement following psilocin administration 2026-04-10 · Expand citations
    14. Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness-a psychometric analysis using the PES100 in controlled psychedelic studies 2026-03-31 · Expand citations
    15. Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD) 2026-03-26 · Expand citations
    16. Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies 2026-03-19 · Expand citations
    17. Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy 2026-03-01 · Expand citations
    18. Psilocybin and Ibogaine in Cocaine-Seeking: Extinction Enhancement Without Relapse Prevention 2026-03-01 · Expand citations
    19. Psychedelic-assisted psychotherapy: Clarifying the role of the "psychotherapy" 2026-01-01 · Expand citations
    20. Psilocybin and MDMA in Couples Therapy: Investigating Treatment for Substance Use Disorders and Codependency 2025-12-11 · Expand citations
    21. The Psychedelic Psilocin Suppresses Activity of Central Amygdala Corticotropin-Releasing Factor Receptor 1 Neurons and Decreases Ethanol Drinking in Female Mice 2025-12-10 · Expand citations
    22. A causal pluralist theory of the interaction of substance, set and setting in psychedelic experience 2025-11-30 · Expand citations
    23. Exploring the first use of psychedelic macrodoses in Latin American adults: Sociodemographic profiles, consumption factors, and subjective experiences 2025-11-20 · Expand citations
    24. Self-reported improvement in depression, anxiety, and substance use in Spanish-speakers after a memorable psychedelic experience 2025-11-20 · Expand citations
    25. Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondents 2025-11-15 · Expand citations
    26. Hormonal Influences on Psilocybin Responsivity Across the Female Lifespan: Toward Personalized Psychedelic-Assisted Therapy 2025-11-02 · Expand citations
    27. The Medial Prefrontal Cortex Modulates Psychedelic-like Effects of Psilocin 2025-08-08 · Expand citations
    28. Exploring the Frontiers of Psychedelics: A New Chromatographic Method for Detection and Quantification of Psilocybin and Psilocin in Psilocybe cubensis Mushrooms 2025-07-22 · Expand citations
    29. Is there mush-room to improve the environmental sustainability of psilocybin production? 2025-06-10 · Expand citations
    30. Psilocybin and psilocin regulate microglial immunomodulation and support neuroplasticity via serotonergic and AhR signaling 2025-06-01 · Expand citations
    31. Evaluating the Effectiveness of Psychedelic-Assisted Therapy in Treating Alcohol Use Disorders: A Review 2025-05-02 · Expand citations
    32. Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische Anwendung 2025-05-01 · Expand citations
    33. Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile Analysis 2025-04-24 · Expand citations
    34. Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans 2025-04-21 · Expand citations
    35. Psychedelics for Substance Use Disorders: Updates for the Psychiatric Trainee 2025-03-06 · Expand citations
    36. BROAD SPECTRUM OF THERAPEUTIC PROPERTIES OF PSILOCYBIN: A LITERATURE REVIEW 2025-02-20 · Expand citations
    37. Narrative review of psilocybin, an important psychoactive substance with potential peri-anesthetic implications 2024-11-30 · Expand citations
    38. The molecular structure, vibrational spectra, solvation effect, non-covalent interactions investigations of psilocin 2024-11-01 · Expand citations
    39. Change in occupational burnout measures in emergency medical service workers after a psychedelic experience induced by a single self-administered dose of psilocybin mushrooms 2024-09-09 · Expand citations
    40. PTSD Treatment: An Inquiry into the Promising Potential of Psilocybin 2024-07-24 · Expand citations
    41. Psychedelic trip sitting, dosages and intensities: Supplementing clinical studies with anecdotal reports 2024-07-17 · Expand citations
    42. Assessment of psychedelic--induced states: Norwegian translation and adaptation of the revised Mystical Experience Questionnaire (MEQ-30) 2024-07-12 · Expand citations
    43. Psilocybin in the Management of Substance Use Disorders: A Summary ofCurrent Evidence 2024-07-04 · Expand citations
    44. Pharmacotherapy of Psychological Disorders Using Psychedelic Drugs: A Treatise for Psychiatrists 2024-01-21 · Expand citations
    45. In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin 2024-01-08 · Expand citations
    46. Psychedelics: The New Kid on the Block 2024-01-01 · Expand citations
    47. The potential of psilocybin use to enhance well-being in healthy individuals - A scoping review 2023-11-29 · Expand citations
    48. The Potential Therapeutic Benefits and Safety of Psychedelics in the Treatment of Mental Health Conditions: A Systematic Review 2023-11-06 · Expand citations
    49. Psilocybin-assisted psychotherapy for the treatment of PTSD in UK armed forces veterans: A feasibility study protocol 2023-10-25 · Expand citations
    50. Christian Responses to Psilocybin-Assisted Therapy and Potential Religious and Spiritual Experiences 2023-10-19 · Expand citations
    51. Psilocybin Use in Palliative Care #464 2023-09-01 · Expand citations
    52. use of psilocybin in the treatment of psychiatric disorders - review 2023-08-15 · Expand citations
    53. The molecular basis of the antidepressant action of the magic mushroom extract, psilocin 2023-07-01 · Expand citations
    54. Psilocybin to promote synaptogenesis in the brains of patients with mild cognitive impairment 2023-04-05 · Expand citations
    55. Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signaling 2023-03-01 · Expand citations
    56. Psychedelic integration challenges: Participant experiences after a psilocybin truffle retreat in the Netherlands 2023-01-16 · Expand citations
    57. Conformational Landscape and Hydrogen Bonding Pattern of Psilocin: Computational Insights 2023-01-09 · Expand citations
    58. The Therapeutic Potential of Psilocybin in Alcohol Use Disorder Recovery: A Literature Review 2023-01-05 · Expand citations
    59. A roadmap for psychedelic pharmacy in Canada: A proposed policy and operations approach for controlled access to select psychedelics for treatment of mental illness 2023-01-01 · Expand citations
    60. Psilocybin in the treatment of generalized anxiety disorder (GAD), alcoholism and smoking: a literature review 2023-01-01 · Expand citations
    61. Direct Quantitation of Psilocybin and Psilocin by One-Dimensional 1H and 31P qNMR in a revived Greek specimen of Psilocybe cyanescens 2022-12-01 · Expand citations
    62. The psychedelic renaissance: can psilocybin possibly combat depression? 2022-11-01 · Expand citations
    63. Psychedelics for Use and Wellbeing Cultural Context and Recent Developments: A Jamaican Perspective 2022-10-28 · Expand citations
    64. Conformational Landscape and Properties of Psilocybin: A Computational Approach 2022-10-04 · Expand citations
    65. P03-21 Magic mushrooms and psilocybin: pharmacokinetics, pharmacodynamics, and clinical applications 2022-09-01 · Expand citations
    66. Psychedelics for Psychiatric Disorders: Promise, Not Panacea 2022-09-01 · Expand citations
    67. Psychedelics in the Treatment of Substance Use Disorders 2022-09-01 · Expand citations
    68. Experiences With Sacred Mushrooms and Psilocybin In Dialogue: Transdisciplinary Interpretations Of The “Velada” 2022-08-09 · Expand citations
    69. Classic and non-classic psychedelics for substance use disorder: A review of their historic, past and current research 2022-06-22 · Expand citations
    70. Charismatic, Synchronous and Psychedelic Religious Experiences: A Personal Account 2022-04-07 · Expand citations
    71. Unravelling a New Conformer of Psilocin Through Computational Methods 2022-01-01 · Expand citations
    72. Conformational Analysis of Psilocybin: A Computational Approach 2021-12-31 · Expand citations
    73. Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey 2021-11-03 · Expand citations
    74. Finding the divine within: exploring the role of the sacred in psychedelic integration therapy for sexual trauma and dysfunction 2021-10-20 · Expand citations
    75. New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances 2021-09-17 · Expand citations
    76. A Qualitative Exploration of Relational Ethical Challenges and Practices in Psychedelic Healing 2021-09-16 · Expand citations
    77. The therapeutical role of psychedelic drugs in treatment of mental disorders 2021-09-15 · Expand citations
    78. Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience 2021-09-01 · Expand citations
    79. Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia Nervosa 2021-06-24 · Expand citations
    80. Psychedelics as a Training Experience for Psychedelic Therapists: Drawing on History to Inform Current Practice 2021-06-23 · Expand citations
    81. Whitewashing psychedelics: racial equity in the emerging field of psychedelic-assisted mental health research and treatment 2021-04-29 · Expand citations
    82. Effectiveness of Psilocybin on Depression: A Qualitative Study 2021-04-27 · Expand citations
    83. Four individuals' experiences during and following a psilocybin truffle retreat in the Netherlands 2021-04-16 · Expand citations
    84. "It kind of polishes all your flaws away": long-term experiences with psilocybin mushrooms and the influence of set and setting 2021-01-01 · Expand citations
    85. The Effect of Psilocybin on Personality 2020-12-31 · Expand citations
    86. Advancing elite athlete mental health treatment with psychedelic-assisted psychotherapy 2020-11-10 · Expand citations
    87. The Role of Psychedelics and Counseling in Mental Health Treatment 2020-10-01 · Expand citations
    88. A potential role for psilocybin in the treatment of obsessive-compulsive disorder 2020-06-01 · Expand citations
    89. Psilocybin for depression: Considerations for clinical trial design 2019-09-01 · Expand citations
    90. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels 2019-06-01 · Expand citations
    91. The influence of therapists’ first-hand experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training 2018-10-05 · Expand citations
    92. Developing Guidelines and Competencies for the Training of Psychedelic Therapists 2017-06-29 · Expand citations
    93. Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression 2017-06-19 · Expand citations
    94. Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis 2017-04-28 · Expand citations
    95. Should addiction researchers be interested in psychedelic science? 2017-04-10 · Expand citations
    96. Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol use 2016-11-14 · Expand citations
    97. Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism 2016-10-16 · Expand citations